Facetten
Zugriff
Einrichtung
Medientyp
Karte
Erscheinungsjahr
Autor/in
- Reich, Kristian
- Augustin, Matthias 5
- Mrowietz, Ulrich 4
- Silverberg, Jonathan I 3
- Simpson, Eric L 3
- alle zeigen
Sprache
22 Einträge gefunden
-
Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis
- Reich, Kristian
- Conrad, Curdin
- Kristensen, Lars Erik
- Smith, Saxon D
- Puig, Luis
- Rich, Phoebe
- Sapin, Christophe
-
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis
- Reich, Kristian
- Baraliakos, Xenophon
- Coates, Laura C
- Elewski, Boni
- Bao, Weibin
- Kasparek, Torben
- Gaillez, Corine
-
Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
- Reich, Kristian
- Thyssen, Jacob P
- Blauvelt, Andrew
- Eyerich, Kilian
- Soong, Weily
- Rice, Zakiya P
- Hong, H Chih-Ho
-
Efficacy and Safety of Ixekizumab Versus Adalimumab in Biologic-naïve Patients With Active Psoriatic Arthritis and Moderate-to-severe Psoriasis: 52-week Results From the Randomized SPIRIT-H2H Trial
- Reich, Kristian
- Kristensen, Lars Erik
- Smith, Saxon D
- Rich, Phoebe
- Sapin, Christophe
- Leage, Soyi Liu
- McKenzie, Robert
-
Measuring patient-relevant benefits in the treatment of psoriasis with the Patient Benefit Index: development and preliminary validation of a 10-item short form
- Blome, Christine
- von Stülpnagel, Catharina C
- Augustin, Matthias
- Mrowietz, Ulrich
- Reich, Kristian
- Muehlan, Holger
- Kirsten, Natalia
-
Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial
- Augustin, Matthias
- Reich, Kristian
- Yamauchi, Paul
- Pinter, Andreas
- Bagel, Jerry
- Dahale, Swapnil
- You, Ruquan
-
-
Nail Involvement as a Predictor of Differential Treatment Effects of Secukinumab Versus Ustekinumab in Patients with Moderate to Severe Psoriasis
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
- Simpson, Eric L
- Merola, Joseph F
- Silverberg, Jonathan I
- Reich, Kristian
- Warren, Richard B
- Staumont-Sallé, Delphine
- Girolomoni, Giampiero
-
Transcriptomic Analysis of Blaschko-Linear Psoriasis Reveals Shared and Distinct Features with Psoriasis Vulgaris
- Onoufriadis, Alexandros
- Niazi, Umar
- Dimitrakopoulou, Konstantina
- Reich, Jeremias
- Ainali, Chrysanthi
- Papanikolaou, Maria
- Kesidou, Evangelia
-
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
- Lebwohl, Mark
- Langley, Richard G
- Paul, Carle
- Puíg, Lluis
- Reich, Kristian
- van de Kerkhof, Peter
- Wu, Hsiuan-Lin
-
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
- Silverberg, Jonathan I
- Simpson, Eric L
- Armstrong, April W
- de Bruin-Weller, Marjolein S
- Irvine, Alan D
- Reich, Kristian
-
Generalized pustular psoriasis: overview of the status quo and results of a panel discussion
- Reich, Kristian
- Augustin, Matthias
- Gerdes, Sascha
- Ghoreschi, Kamran
- Kokolakis, Georgios
- Mößner, Rotraut
- Mrowietz, Ulrich
-
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic Dermatitis
- Reich, Kristian
- Lio, Peter A
- Bissonnette, Robert
- Alexis, Andrew F
- Lebwohl, Mark G
- Pink, Andrew E
- Kabashima, Kenji
-
-
The hair follicle-psoriasis axis: Shared regulatory mechanisms and therapeutic targets
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Maintenance of response in moderate-to-severe psoriasis after withdrawal of the interleukin (IL)-17A and IL-17F nanobody sonelokimab: is there a role for IL-17F in disease reoccurrence?
2022 - Forschungsinformationssystem des UKE - frei zugänglich -
Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO
- Reich, Kristian
- Korge, Bernhard
- Magnolo, Nina
- Manasterski, Maria
- Schwichtenberg, Uwe
- Staubach-Renz, Petra
- Kaiser, Stephan
-
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)
- Bieber, Thomas
- Reich, Kristian
- Paul, Carle
- Tsunemi, Yuichiro
- Augustin, Matthias
- Lacour, Jean-Philippe
- Ghislain, Pierre-Dominique
-
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest
- Reich, Kristian
- Mrowietz, Ulrich
- Sorbe, Christina
- von Kiedrowski, Ralph
- Diemert, Sebastian
- Schaeffer, Lisa
- Kirsten, Natalia